Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,506.48
(
-1.51%
)
US TECH 100
23,296.00
(
-1.79%
)
Dow Jones
45,577.47
(
-0.96%
)
Brent Oil
108.13
(
3.54%
)
Bitcoin
70,024.00
(
0.18%
)
News Focus
News Focus
Post# of 257263
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122803
Boards Moderated 10
Alias Born 09/05/2002

DewDiligence

Member Level

Re: DewDiligence post# 157298

Tuesday, 03/05/2013 2:05:30 PM

Tuesday, March 05, 2013 2:05:30 PM

Post# of 257263

Express Scripts [said] use of [US] cancer drugs [i.e. script volume] last year rose 3.4%, while costs [i.e. aggregate prices] increased 22.3%.

http://online.wsj.com/article/SB10001424127887323494504578340393335386084.html

Inasmuch as the growth in aggregate prices outran the growth in volume by almost seven-fold, the price of the average US cancer drug clearly increased dramatically in 2012 vs 2011.

The above figures exclude Medicare and Medicaid. ESRX, one of the 3 large US PBM’s, handled 1.4 billion US prescriptions in 2012.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today